Osteoporosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 40 to 95 years old, of any gender
- People who have been admitted to hospital with a spinal fracture (a collapsed vertebra) caused by either osteoporosis or an injury
- People whose fracture is located in a specific section of the mid-to-lower spine (between the 6th thoracic and 5th lumbar vertebrae — confirm with trial site if unsure where your fracture sits)
- People with stable vital signs (such as heart rate and blood pressure) and liver and kidney function results that are within an acceptable range, as judged by the study doctor
- People who are willing to follow the study schedule and attend all required appointments and assessments
- People who are fully conscious, mentally alert, and able to read and sign a consent form independently
Who may not be able to join:
- People whose spinal fracture was caused by a bone disease such as a tumour (benign or cancerous), tuberculosis, bone infection, a hormonal or metabolic bone condition, or severe bone degeneration
- People who currently have an active or serious infection anywhere in the body
- People with metabolic conditions (such as calcium processing problems), immune system disorders, substance misuse issues, or alcohol dependency
- People with serious conditions affecting blood cell production or the hormonal system, or people with a diagnosed psychiatric disorder
- People with a known allergy to implant materials, a history of severe allergic reactions, or allergies to multiple medications
- People whose bone around the surgical site is not healthy enough or strong enough to support the implant
- People who have an active infection at or near the area where surgery would be performed
- People with an unstable spine in the area of the fracture that poses an acute risk
- People who are unwilling or unable to limit physical activity or follow medical instructions during the study
- People whom the study doctor considers unsuitable for participation for any reason, or who are unable to give independent consent
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dr. Chih-Chien Wang, Ph.D., Trial-Service General Hospital, National Defense Medical University
Phone: 886-2-87923100
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of Adverse Events, Serious Adverse Events (SAEs), and Unanticipated Serious Adverse Device Effects (USADEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.